Nymox Pharmaceutical Corporation NYMXF
OTC PK
| 12/31/2024 | 12/31/2023 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 80.49% | -7.89% | |||
| Total Receivables | 17.39% | 57.14% | |||
| Inventory | -- | -- | |||
| Prepaid Expenses | -30.43% | -97.05% | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | 0.00% | 1,785.71% | |||
| Total Current Assets | 4.82% | -4.43% | |||
|
|
|||||
| Total Current Assets | 4.82% | -4.43% | |||
| Net Property, Plant & Equipment | 0.00% | -86.67% | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | -- | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | -- | -- | |||
| Total Assets | 4.81% | -6.28% | |||
|
|
|||||
| Total Accounts Payable | -4.61% | 18.09% | |||
| Total Accrued Expenses | -- | -- | |||
| Short-term Debt | 26.09% | -- | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | -- | -- | |||
| Total Finance Division Other Current Liabilities | -- | -- | |||
| Total Other Current Liabilities | -- | -- | |||
| Total Current Liabilities | 7.36% | 47.80% | |||
|
|
|||||
| Total Current Liabilities | 7.36% | 47.80% | |||
| Long-Term Debt | -- | -- | |||
| Short-term Debt | 26.09% | -- | |||
| Capital Leases | -- | -- | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | -- | -- | |||
| Total Liabilities | 7.36% | 47.80% | |||
|
|
|||||
| Common Stock & APIC | 0.14% | 0.41% | |||
| Retained Earnings | -0.40% | -2.62% | |||
| Treasury Stock & Other | 2.42% | -- | |||
| Total Common Equity | -7.61% | -66.82% | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | -- | -- | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | -- | -- | |||
|
|
|||||
| Total Common Equity | -7.61% | -66.82% | |||
| Total Preferred Equity | -- | -- | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | -7.61% | -66.82% | |||
|
|
|||||